Candel Therapeutics | 8-K: Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Candel Therapeutics | 8-K: Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
Candel Therapeutics | 8-K: Current report
No Data